http://pharmtech.findpharma.com/pharmtech A publication providing practical information on pharmaceutical manufacturing. Content focuses on applied R&D technology, process control and computer-integrated manufacturing, biotechnology and technical management. 2010-02-09T18:33:00Z http://pharmtech.findpharma.com/pharmtech/Pfizers-Maddaluna-on-Integrating-Wyeths-Manufactur/ArticleStandard/Article/detail/655872?ref=25 2010-02-08T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/072010/655872null HTML http://pharmtech.findpharma.com/pharmtech/FDA-requests-another-major-year-over-year-budget-i/ArticleStandard/Article/detail/655022?ref=25 Less than a week after president Obama proposed a spending freeze on non-security related federal programs, the FDA released its fiscal year 2011 budget request, calling for a 23% increase. 2010-02-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655022null HTML http://pharmtech.findpharma.com/pharmtech/Pfizer-streamlines-and-prioritizes-pipeline/ArticleStandard/Article/detail/655019?ref=25 Pfizer?s first updated pipeline since its acquisition of Wyeth includes fewer projects than before and is targeted to specific diseases; after the acquisition, the companies? combined pipeline had 600 projects, but the number has been reduced to about 500. 2010-02-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655019null HTML http://pharmtech.findpharma.com/pharmtech/AstraZeneca-announces-jobs-cuts-and-RampD-restruct/ArticleStandard/Article/detail/655018?ref=25 AstraZeneca plans to undertake further restructuring in its R&D operations, resulting in the elimination of 3500 jobs. 2010-02-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655018null HTML http://pharmtech.findpharma.com/pharmtech/News/Capsules-enable-on-demand-drug-release/ArticleStandard/Article/detail/655023?ref=25 Capsules that can release their contents at a selected temperature have been developed by researchers in France, and could lead to the development of therapeutic agents that are applied to the skin and triggered locally by rubbing. 2010-02-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655023null HTML http://pharmtech.findpharma.com/pharmtech/News/Product-planning-groups-integral-to-drive-profitab/ArticleStandard/Article/detail/655025?ref=25 A highly functioning New Product Planning (NPP) group is a company's first line of defence against losses caused by products that fail to reach the market, according to research and consulting firm Best Practices LLC. 2010-02-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655025null HTML http://pharmtech.findpharma.com/pharmtech/The-Pharma-Congress-Production-amp-Technology/ArticleStandard/Article/detail/651936?ref=25 The Pharma Congress Production & Technology has been Germany's leading convention in the pharma environment for 11 years, combining high-class special subject matter conferences, an adjacent exhibition and directly connected hotel accommodation. Last year, nearly 400 delegates, exhibitors and visitors attended. 2010-02-05T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651936null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Pfizer-Streamlines-and-Prioritizes-Pipeline/ArticleStandard/Article/detail/654959?ref=25 Pfizer's first updated pipeline since its acquisition of Wyeth includes fewer projects than before and is targeted to specific diseases. 2010-02-04T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654959null HTML http://pharmtech.findpharma.com/pharmtech/Regulation+News/FDA-Requests-Another-Major-Budget-Increase/ArticleStandard/Article/detail/654847?ref=25 Less than a week after president Obama proposed a spending freeze on nonsecurity-related federal programs, the US Food and Drug Administration released its fiscal year 2011 budget request, calling for a 23% increase. 2010-02-04T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654847null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Feb-1-2010-Company-and-People-Notes-Cephal/ArticleStandard/Article/detail/654945?ref=25 Cephalon Buys Mepha; BASi's CEO Retires; and More. 2010-02-04T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654945null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Gates-Foundation-Pledges-10-Billion-for-Vaccines/ArticleStandard/Article/detail/654835?ref=25 Hoping to prevent the deaths of eight million children over the next decade, Bill and Melinda Gates recently committed $10 billion for child-immunization programs in the world's poorest countries. 2010-02-04T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654835null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Issues-Draft-Guidance-on-Drugs-with-Potential-/ArticleStandard/Article/detail/654845?ref=25 The US Food and Drug Administration issued a draft guidance for industry, Assessment of Abuse Potential of Drugs, in late January. 2010-02-04T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654845null HTML http://pharmtech.findpharma.com/pharmtech/Regulation+News/Regulatory-Roundup-FDA-Releases-Annual-Guidance-Ag/ArticleStandard/Article/detail/654880?ref=25 FDA Releases Annual Guidance Agenda; OMB Urges Obama to Issue Revised Executive Order. 2010-02-04T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654880null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/AstraZeneca-Announces-Jobs-Cuts-and-RampD-Restruct/ArticleStandard/Article/detail/655046?ref=25 AstraZeneca announced this week that it plans to undertake further restructuring in its research and development operations, resulting in the elimination of 3500 jobs. 2010-02-04T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655046null HTML http://pharmtech.findpharma.com/pharmtech/Symetix-Accela-Form---Bulk-Inspection-of-Tablets-A/ArticleStandard/Article/detail/655283?ref=25 Symetix Accela Form - Bulk Inspection of Tablets: Assuring Product Quality at Manufacturing and Packaging 2010-02-03T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655283null HTML http://pharmtech.findpharma.com/pharmtech/Tracking-API-Growth/ArticleStandard/Article/detail/654609?ref=25 Growth in emerging markets and across the generic-drug sector shifts the global demand and supply of active pharmaceutical ingredients. 2010-02-03T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654609/Ingredients-column.p46_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654609null XML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Bulk-Inspection-of-Tablets-Assuring-Product-Qualit/ArticleStandard/Article/detail/655300?ref=25 Achieve new levels of product quality and inspection efficiency in the manufacturing and packaging of tablets. Learn the pros and cons of manual inspection, mechanical sorting, blistering, single-file optical systems and a new class of automated bulk vision inspection systems. The latest technology ensures top-quality products while minimizing risk, increasing throughput and containing costs. 2010-02-03T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655300null REMOTE http://pharmtech.findpharma.com/pharmtech/DCAT-Rolls-Out-Educational-Programming-for-DCAT-We/ArticleStandard/Article/detail/654605?ref=25 The rising importance of generic drugs, evolving requirements in the ever-more global supply chain, and supplier-management strategies in biologics manufacturing are some key topics to be addressed next month during DCAT Week. 2010-02-03T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654605null HTML http://pharmtech.findpharma.com/pharmtech/A-Look-Ahead-for-2010/ArticleStandard/Article/detail/654613?ref=25 Some predictions for contract services in 2010. 2010-02-03T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654613null XML http://pharmtech.findpharma.com/pharmtech/Bulk-Inspection-of-Tablets-Assuring-Product-Qualit/ArticleStandard/Article/detail/655282?ref=25 Bulk Inspection of Tablets: Assuring Product Quality at Manufacturing and Packaging - Symetix Whitepaper 2010-02-03T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655282null PDF http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/QampA-with-Jim-Vaughan-of-3M-Drug-Delivery-Systems/ArticleStandard/Article/detail/655280?ref=25 3M Drug Delivery Systems Division Vice President Jim Vaughan discusses facility locations and the drug-product inhalation market. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655280/Pharma-Caps-article-P70_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655280null XML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Breaking-Down-Barriers-to-Oral-Delivery/ArticleStandard/Article/detail/655092?ref=25 A recent book provides information about formulating biopharmaceuticals that is easy to swallow. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655092/Cecil-Book-CV_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655092null XML http://pharmtech.findpharma.com/pharmtech/IT/Innovation-Today-Rewards-Tomorrow/ArticleStandard/Article/detail/654759?ref=25 When it comes to healthcare rform, we must not overlook investment in innovative technologies. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654759null XML http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Advances-in-Custuom-Synthesis/ArticleStandard/Article/detail/654744?ref=25 As contract manufacturers and drug companies meet at Informex, the stage is set for the latest in pharmaceutical chemical development. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654744null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/The-eCTD-Upgrade-Cross-Application-Linking/ArticleStandard/Article/detail/654751?ref=25 How to cut time and cost by re-using already submitted documents. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654751/PT0210_WEB_eCTD_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654751/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654751null XML http://pharmtech.findpharma.com/pharmtech/Article/In-the-Spotlight/ArticleStandard/Article/detail/654749?ref=25 Editors' Picks of Pharmaceutical Science & Technology Innovations 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654749null XML http://pharmtech.findpharma.com/pharmtech/Article/Managing-Change-Control-in-a-Changing-Environment/ArticleStandard/Article/detail/654747?ref=25 We never thought implementing complex changes could become more cumbersome. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654747null XML http://pharmtech.findpharma.com/pharmtech/Article/Implications-and-Opportunities-of-Applying-QbD-Pri/ArticleStandard/Article/detail/654746?ref=25 The authors present two concepts to improve robustness and facilitate continuous improvement in analytical methods. This article contain bonus online material. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654746/Schweitzer-p57_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654746/Bonus_main.gif http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654746null XML http://pharmtech.findpharma.com/pharmtech/IT/Is-the-Internet-to-Blame-for-Unsafe-Drug-Use/ArticleStandard/Article/detail/654750?ref=25 FDA impersonators and counterfeit drugs threaten the public's trust in online pharmacies. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654750null XML http://pharmtech.findpharma.com/pharmtech/IT/The-Talk-of-the-Lab/ArticleStandard/Article/detail/654758?ref=25 Sharing too much—or too little—information can have disastrous onsequences. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654758null XML http://pharmtech.findpharma.com/pharmtech/Outsourcing-Form/ArticleStandard/Article/detail/654801?ref=25 Outsourcing Form 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654801null HTML http://pharmtech.findpharma.com/pharmtech/Article/PAT-A-New-Dawn-for-Drug-Product-Quality/ArticleStandard/Article/detail/655093?ref=25 Leading experts share insight on the current and future direction of process analytical technology. This article contains bonus online material. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655093/CV-story-p38_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655093/Bonus_main.gif http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655093null XML http://pharmtech.findpharma.com/pharmtech/IT/Manufacturers-Look-to-Vaccines-for-Growth-and-Inno/ArticleStandard/Article/detail/654756?ref=25 Vaccine R&D is surging, but continues to raise manufacturing and regulatory challenges. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654756null XML http://pharmtech.findpharma.com/pharmtech/Editors%27+Forum/Science-and-Sensibility/ArticleStandard/Article/detail/654752?ref=25 The death of a pioneer in molecular genetics recalls age-old questions about social fitness to ensure the ethical uses of scientific advances. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654752null XML http://pharmtech.findpharma.com/pharmtech/Ingredients/Specialty-Pharmaceutical-Focus-Pancreatic-Enzyme-P/ArticleStandard/Article/detail/654748?ref=25 A look at the formulation challenges in pancreatic enzyme products. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654748/onlineEX_main.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654748null XML http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/A-Bio-View-of-Outsourcing/ArticleStandard/Article/detail/654757?ref=25 Strategic rather than tactical considerations are driving biopharmaceutical outsourcing. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654757null XML http://pharmtech.findpharma.com/pharmtech/Copley-Accela-Form---Assessing-dry-powder-inhalers/ArticleStandard/Article/detail/654870?ref=25 Copley Accela Form - Assessing dry powder inhalers 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654870null HTML http://pharmtech.findpharma.com/pharmtech/IT/In-the-Field-Report-from-Europe/ArticleStandard/Article/detail/654745?ref=25 Regulators and industry move to require inspections of API manufacturing facilities. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654745/Europe-P18_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654745null XML http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Assessing-dry-powder-inhalers/ArticleStandard/Article/detail/654899?ref=25 The performance characterisation of dry powder inhalers (DPI) recognises the importance of three factors: the device, the formulation and the patient. Successful product development demands an understanding of how each of these shapes drug delivery, and how to test the product in a relevant way. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654899null REMOTE http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Do-Visible-Residue-Limits-Make-the-10-ppm-Carryove/ArticleStandard/Article/detail/654755?ref=25 The author discusses how the use of a visible residue limit has made the 10-ppm cleaning limit obsolete in many applications. 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654755null XML http://pharmtech.findpharma.com/pharmtech/Assessing-dry-powder-inhalers---Copley-Whitepaper/ArticleStandard/Article/detail/654868?ref=25 Assessing dry powder inhalers - Copley Whitepaper 2010-02-02T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654868null PDF http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Multivariate-data-analysis-easily-retrieves-insigh/ArticleStandard/Article/detail/655365?ref=25 Statistics are often viewed as confusing and complicated, but multivariate data analysis (MVA) methods can be used to amass knowledge simply. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655365/Thissen_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655365null XML http://pharmtech.findpharma.com/pharmtech/Debunking-Myths-About-Buying-Pre-Owned-Equipment--/ArticleStandard/Article/detail/654519?ref=25 Debunking Myths About Buying Pre-Owned Equipment - EquipNet Whitepaper 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654519null PDF http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/Water-based-nanotechnology/ArticleStandard/Article/detail/641173?ref=25 Eran Gabbai, CEO and President of Do-Coop Technologies, explains the benefits of a new water-based nanotechnology. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/641173/web_thumb_thumbnail.gif http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/641173null HTML http://pharmtech.findpharma.com/pharmtech/News/ArticleStandard/Article/detail/655364?ref=25 A round up of news from across the globe. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655364null XML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Rise-of-the-robots/ArticleStandard/Article/detail/655359?ref=25 Although once used only for large production processes, robotics are now working their way into every aspect of the pharma manufacturing processes. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655359null XML http://pharmtech.findpharma.com/pharmtech/Commercialising-cellular-therapies-faster/ArticleStandard/Article/detail/654435?ref=25 There is much scientific evidence of the early successes of whole cell therapies as disease cures in chronic conditions and disease-modifiers in acute conditions, but limited cases of successfully transferring these discoveries to commercial products or therapies 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654435null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Reducing-the-risk-of-microbial-contamination/ArticleStandard/Article/detail/654440?ref=25 Maintaining asepsis and sterility is the primary challenge to implementing aseptic techniques and sterile processes in biopharmaceutical manufacture. Efforts to reduce the risk of microbial contamination of aseptically filled biotech products beyond their already low level represent engineering challenges, that don?t really compliment the progress in biotech R&D. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654440null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Trends-and-challenges-of-biopharma-manufacturing/ArticleStandard/Article/detail/654438?ref=25 The whole pharma/biopharma industry is under pressure to deliver cost-effective new drugs; however, the number of new drug applications is getting lower as the size of investment is increasing. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654438/Rathore_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654438null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing+Whitepaper/Debunking-Myths-About-Buying-Pre-Owned-Equipment/ArticleStandard/Article/detail/654594?ref=25 In the new eBook, "Purchasing Reality Check," EquipNet debunks common myths about buying pre-owned industrial 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654594null REMOTE http://pharmtech.findpharma.com/pharmtech/Regulation+Article/Cushioning-pharmas-fall-from-the-patent-precipice/ArticleStandard/Article/detail/655367?ref=25 Pharma faces imminent expiries of key patents and increasing competition from generics. To protect what they already have, or what they will invent or acquire, companies must give patent protection the attention it deserves. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655367/Evans_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655367null XML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Achieving-site-specific-PEGylation/ArticleStandard/Article/detail/654439?ref=25 PEGylation has been around for 30 years and it is surprising that it is still widely used given the significant advances that have been made in biopharmaceutical manufacture since then. So why is this the case? 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654439null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Disposables-help-overcome-some-challenges-of-vacci/ArticleStandard/Article/detail/654434?ref=25 The vaccine sector is challenging for both R&D and manufacturing because a wide variety of technologies and techniques are required — even the largest companies find it difficult to cover all the relevant areas of expertise — and this drives up development costs and often forces companies into multiple collaborations to obtain the required expertise and technologies. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654434null HTML http://pharmtech.findpharma.com/pharmtech/Editor%27s+comment/Is-change-good-for-you/ArticleStandard/Article/detail/655369?ref=25 With the pharmaceutical industry being in a current state of unrest in light of the recent spate of mergers, acquisitions, job cuts, divestments, patent expiries, and so on, we wanted to know how you felt about all these changes that will have directly or indirectly affected you. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655369null XML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Boosting-efficiency-and-safety-by-minimising-aggre/ArticleStandard/Article/detail/654437?ref=25 Last year, the UK's National Institute for Health and Clinical Excellence (NICE) decided that a new biopharmaceutical cancer drug costing £3000 per month, which could extend a patient's life by 6 months, was not value for money and would not be prescribed in the UK. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654437null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Biopharmaceuticals-saving-the-future-of-our-indust/ArticleStandard/Article/detail/655366?ref=25 Pharmaceutical Technology Europe discusses some of the latest challenges and innovations that are expected to define the future of pharma. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655366/Rathore_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655366null XML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Commercialising-cellular-therapies-faster/ArticleStandard/Article/detail/655360?ref=25 There is much scientific evidence of the early successes of whole cell therapies as disease cures in chronic conditions and disease-modifiers in acute conditions, but limited cases of successfully transferring these discoveries to commercial products or therapies. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655360null XML http://pharmtech.findpharma.com/pharmtech/Regulation+Article/EU-pricing-dilemmas/ArticleStandard/Article/detail/655368?ref=25 Although representing a huge market, the EU also presents problems that hamper profitability— particularly when it comes to differing price regulations across member states. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655368null XML http://pharmtech.findpharma.com/pharmtech/Quality-by-Design-for-biotechnology-products-chall/ArticleStandard/Article/detail/653710?ref=25 References for the article published in the February issue of Pharmaceutical Technology Europe. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/052010/653710null HTML http://pharmtech.findpharma.com/pharmtech/Your-predictions-for-2010/ArticleStandard/Article/detail/655361?ref=25 Just before the end of 2009 we gave visitors to our website the opportunity to make some predictions about the 2010 pharma industry… and now it's time for the results. 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/655361null XML http://pharmtech.findpharma.com/pharmtech/EquipNet-Accela-Form---Debunking-Myths-About-Buyin/ArticleStandard/Article/detail/654525?ref=25 EquipNet Accela Form - Debunking Myths About Buying Pre-Owned Equipment 2010-02-01T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/062010/654525null HTML http://pharmtech.findpharma.com/pharmtech/Plan-outlined-for-European-generics/ArticleStandard/Article/detail/653574?ref=25 The Director General of the European Generic medicines Association (EGA) has reiterated the association?s Vision 2015 plan, which aims to create a globally competitive generic industry, increase patient access to affordable quality medicines and ensure sustainable healthcare in Europe. 2010-01-29T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/052010/653574null HTML http://pharmtech.findpharma.com/pharmtech/WHO-denies-industry-influence-on-pandemic-response/ArticleStandard/Article/detail/653708?ref=25 The World Health Organization?s (WHO) response to the H1N1 pandemic was not improperly influenced by the pharmaceutical industry, Keiji Fukuda, special adviser on pandemic influenza to the WHO?s Director General, explained at a hearing held by the Council of Europe to address concerns over the WHO?s reaction to the pandemic. 2010-01-29T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/052010/653708null HTML http://pharmtech.findpharma.com/pharmtech/Nanotechnology-safety-legislation-introduced/ArticleStandard/Article/detail/653575?ref=25 Two US senators have introduced the Nanotechnology Safety Act of 2010, which would establish a programme within the FDA to assess the health and safety implications of nanotechnology in everyday products. 2010-01-29T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/052010/653575null HTML http://pharmtech.findpharma.com/pharmtech/EMA-outlines-priorities-for-20101502015/ArticleStandard/Article/detail/653711?ref=25 The EMA has launched a public consultation on its Road Map to 2015 — a strategic vision that lays out the agency's priorities for the next 5 years. 2010-01-29T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/052010/653711null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/New-Plan-for-Generic-Drugs-in-Europe/ArticleStandard/Article/detail/653602?ref=25 The Director-General of the European Generic medicines Association has reiterated the group's Vision 2015 plan. 2010-01-28T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/052010/653602null HTML http://pharmtech.findpharma.com/pharmtech/Regulation+News/Senate-Introduces-Nanotechnology-Safety-Legislatio/ArticleStandard/Article/detail/653588?ref=25 Two US senators have introduced the Nanotechnology Safety Act of 2010, which would establish a program within the US Food and Drug Administration to assess the health and safety implications of nanotechnology in everyday products. 2010-01-28T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/052010/653588null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/WHO-Denies-Improper-Pharmaceutical-Industry-Influe/ArticleStandard/Article/detail/653654?ref=25 Keiji Fukuda, special adviser on pandemic influenza to the World Health Organization's (WHO) director-general, told a hearing at the Council of Europe that WHO's response to the influenza (H1N1) pandemic was not improperly influenced by the pharmaceutical industry. 2010-01-28T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/052010/653654null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/EMA-outlines-priorities-for-20101502015/ArticleStandard/Article/detail/653800?ref=25 The European Medicines Agency has launched a public consultation on its Road Map to 2015, a strategic vision that lays out the agency's priorities for the next five years. 2010-01-28T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/052010/653800null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/Regulatory-Roundup-New-York-Governor-Wants-Stricte/ArticleStandard/Article/detail/653585?ref=25 New York Governor Wants Stricter Limits On Pharmaceutical Marketing; And More. 2010-01-28T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/052010/653585null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-Of-Jan-25-2010-Company-And-People-Notes-Novar/ArticleStandard/Article/detail/653578?ref=25 Novartis CEO To Step Down; DSM To Close Netherlands Facility; And More. 2010-01-28T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/052010/653578null HTML http://pharmtech.findpharma.com/pharmtech/Corporate-Capabilities-2010/ArticleStandard/Article/detail/653651?ref=25 Company profiles from the December 2009 Corporate Capabilities publication. 2010-01-28T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/052010/653651/ptcc1209_cv1r1_thumbnail.jpg http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/052010/653651null HTML http://pharmtech.findpharma.com/pharmtech/JampJ-voluntarily-recalls-certain-OTC-products/ArticleStandard/Article/detail/652761?ref=25 Johnson & Johnson is recalling a number of products because of reports of an unusual mouldy, musty, or mildew-like odour that has been associated with nausea, stomach pain, vomiting or diarrhea in a small number of cases. 2010-01-22T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/042010/652761null HTML http://pharmtech.findpharma.com/pharmtech/EU-outlines-health-priorities/ArticleStandard/Article/detail/652763?ref=25 The EU?s Commissioner-designate for Health and Consumer Policy, John Dalli, has said that he is looking forward to the challenge of integrating the pharmaceutical area into public health as part of his role. 2010-01-22T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/042010/652763null HTML http://pharmtech.findpharma.com/pharmtech/News/Nanoburrs-offer-targeted-cardiovascular-treatment/ArticleStandard/Article/detail/652762?ref=25 Targeted nanoparticles that can cling to artery walls and slowly release medicine could offer an alternative to drug-releasing stents in some patients with clogged or damaged arteries, according to researchers at the Massachusetts Institute of Technology (MIT) and the Harvard Medical School. 2010-01-22T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/042010/652762null HTML http://pharmtech.findpharma.com/pharmtech/Most+Viewed+Articles/Lonza-closes-sites-in-North-America-and-UK/ArticleStandard/Article/detail/652760?ref=25 In response to economic pressures, the Lonza Group will close three sites in 2010 in North America and in the UK, which will affect 175 employees. 2010-01-22T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/042010/652760null HTML http://pharmtech.findpharma.com/pharmtech/Serialization-Strategies-for-Today-amp-Tomorrow---/ArticleStandard/Article/detail/653051?ref=25 Serialization Strategies for Today & Tomorrow - Systech Whitepaper 2010-01-21T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/042010/653051null PDF http://pharmtech.findpharma.com/pharmtech/Systech-Accela-Form---Serialization-Strategies-for/ArticleStandard/Article/detail/653050?ref=25 Systech Accela Form - Serialization Strategies for Today & Tomorrow 2010-01-21T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/042010/653050null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/EU-Outlines-Health-Priorities/ArticleStandard/Article/detail/652787?ref=25 The EU's Commissioner-designate for Health and Consumer Policy, John Dalli, said that he is looking forward to the challenge of integrating the pharmaceutical area into public health as part of his role. 2010-01-21T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/042010/652787null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-Of-Jan-18-2010-Company-And-People-Notes-FDA-I/ArticleStandard/Article/detail/652688?ref=25 FDA Issues Warning Letter To McNeil Healthcare; Charles River Laboratories Will Suspend Operations At Massachusetts Facility. 2010-01-21T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/042010/652688null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/Regulatory-Roundup-FDA-Thanks-Healthcare-Workers-F/ArticleStandard/Article/detail/652703?ref=25 FDA Thanks Healthcare Workers For H1N1 Response; And More. 2010-01-21T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/042010/652703null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/Lonza-Closes-Sites-in-North-America-and-UK/ArticleStandard/Article/detail/652713?ref=25 Lonza Group (Basel) plans to reinforce its presence in Asia, including its platform in Nansha, China, and to close its Conshohocken (Riverside), Pennsylvania; Shawinigan, Canada; and Wokingham, United Kingdom, sites in 2010. 2010-01-21T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/042010/652713null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/JampJ-Voluntarily-Recalls-Certain-OTC-Products/ArticleStandard/Article/detail/652691?ref=25 McNeil Consumer Healthcare is voluntarily recalling certain lots of over-the-counter products in the Americas, the United Arab Emirates, and Fiji. 2010-01-21T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/042010/652691null HTML http://pharmtech.findpharma.com/pharmtech/Online+Only/Biopharmaceutical-Manufacturers-Look-for-Flexibili/ArticleStandard/Article/detail/651946?ref=25 Could flexible manufacturing change the standards for biopharmaceutical production? To find out, Equipment and Processing Report talked to James Robinson, vice-president of technical and quality operations at biotechnology company Novavax (Rockville, MD). 2010-01-20T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651946null HTML http://pharmtech.findpharma.com/pharmtech/Nanoburrs-Offer-Targeted-Cardiovascular-Treatment/ArticleStandard/Article/detail/652784?ref=25 Targeted nanoparticles that can cling to artery walls and slowly release medicine could offer an alternative to drug-releasing stents in some patients with clogged or damaged arteries, according to researchers at the Massachusetts Institute of Technology (MIT) and the Harvard Medical School. 2010-01-20T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/042010/652784null HTML http://pharmtech.findpharma.com/pharmtech/Pharm-Tech-Outsourcing-Resources-Form/ArticleStandard/Article/detail/652738?ref=25 Pharm Tech Outsourcing Resources Form 2010-01-19T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/042010/652738null HTML http://pharmtech.findpharma.com/pharmtech/News/Novartis-faces-legal-action-over-Alcon-merger/ArticleStandard/Article/detail/651410?ref=25 A class of action has been filed that seeks to prevent Novartis' proposed merger with eye-care company Alcon, which will see Alcon's minority public shareholders "squeezed out at an unfair price", according to a statement from US law firm Labaton Sucharow LLP. 2010-01-15T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651410null HTML http://pharmtech.findpharma.com/pharmtech/EC-probes-patent-settlements/ArticleStandard/Article/detail/651409?ref=25 The EC has asked certain pharmaceutical companies to submit copies of their patent settlement agreements; in particular, the EC will be looking at settlements where an originator paid off a generic competitor in return for delayed market entry of a generic drug. 2010-01-15T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651409null HTML http://pharmtech.findpharma.com/pharmtech/USP-recalls-latest-monographs/ArticleStandard/Article/detail/651605?ref=25 The US Pharmacopeial Convention (USP) is recalling USP 33?NF 28. 2010-01-15T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651605null HTML http://pharmtech.findpharma.com/pharmtech/SOCMA-outlines-legislative-goals-for-2010/ArticleStandard/Article/detail/651603?ref=25 The international Society of Chemical Manufacturers and Affiliates (SOCMA) has outlined its legislative priorities for 2010 for the second session of 111th Congress, plans for its national grassroots program — SOCMA Connect — and efforts to launch a voter-registration drive ahead of the November mid-term elections. 2010-01-15T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651603null HTML http://pharmtech.findpharma.com/pharmtech/More-mergers-and-acquisitions-ahead-for-2010/ArticleStandard/Article/detail/651408?ref=25 Many life sciences companies are likely to execute an acquisition in the next 12–24 months as economic conditions improve, according to Why capital matters, a global survey of senior executives in the life sciences sector conducted by Ernst & Young in 2009. 2010-01-15T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651408null HTML http://pharmtech.findpharma.com/pharmtech/In+the+Mixer/Large-Scale-Protein-Production-with-a-Cell-Free-Sy/ArticleStandard/Article/detail/651951?ref=25 The authors sought to improve the productivity of protein synthesis by using a highly active cell-free extract from Escherichia coli and by optimizing buffer conditions and shaking conditions. 2010-01-14T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651951null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/SOCMA-Outlines-Legislative-Goals-for-2010/ArticleStandard/Article/detail/651546?ref=25 The Society of Chemical Manufacturers and Affiliates outlined its legislative priorities for the second session of the 111th Congress. 2010-01-14T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651546null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/USP-Recalls-Latest-Monographs/ArticleStandard/Article/detail/651489?ref=25 The United States Pharmacopeial Convention is recalling USP 33?NF 28. 2010-01-14T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651489null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Publishes-Guidance-for-the-Production-of-Medic/ArticleStandard/Article/detail/651533?ref=25 The US Food and Drug Administration published a guidance last week intended to ensure the availability of medically necessary drug products during emergencies. 2010-01-14T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651533null HTML http://pharmtech.findpharma.com/pharmtech/Regulation/EC-Probes-Patent-Settlements/ArticleStandard/Article/detail/651481?ref=25 The European Commission has asked certain pharmaceutical companies to submit copies of their patent-settlement agreements. 2010-01-14T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651481null HTML http://pharmtech.findpharma.com/pharmtech/Manufacturing/More-Mergers-and-Acquisitions-Ahead-for-2010/ArticleStandard/Article/detail/651486?ref=25 Many life-sciences companies are likely to execute an acquisition in the next 12-24 months, according to a survey by Ernst & Young. 2010-01-14T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651486null HTML http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Jan-11-2010-Company-And-People-Notes-Facil/ArticleStandard/Article/detail/651499?ref=25 Facility of the Year Awards Announced; Eisai Completes Acquisition Of AkaRx; And More. 2010-01-14T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651499null HTML http://pharmtech.findpharma.com/pharmtech/Editor%27s+Picks/January-2010-Editors-Picks-Products-from-Malvern-a/ArticleStandard/Article/detail/651975?ref=25 PharmTech's monthly newsletter, Equipment & Processing Report, reviews the Editor's Picks for the January 2010 edition from Malvern and OYSTAR. 2010-01-14T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651975null HTML http://pharmtech.findpharma.com/pharmtech/What-are-Mycoplasmas---Bionique-Whitepaper-Revised/ArticleStandard/Article/detail/651717?ref=25 What are Mycoplasmas? - Bionique Whitepaper Revised 2010-01-13T05:00:00Z http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/032010/651717null PDF